Chemotherapy use at the end of life in metastatic non small cell lung cancer: practical analysis

Journal Title: JOURNAL OF FUNCTIONAL VENTILATION AND PULMONOLOGY - Year 2017, Vol 8, Issue 25

Abstract

Background. End of life cancer care has become more aggressive. Scarce studies have explored the factors associated with the aggressiveness of cancer care near the end of life (EOL) in non-small cell lung cancer (NSCLC) patients. The aim of the study was to evaluate chemotherapy use at the EOL in patients with primary metastatic NSCLC. Methods. We conducted a retrospective study which included expired patients diagnosed with primary metastatic NSCLC and who died within 3 months of diagnosis between January 2007 and December 2013 in our thoracic oncology unit. Results. A total of 183 patients were included. Median age of the patients was 60 years old. The proportion of patients who received chemotherapy in the last three months of life was 31.9%, in the last month 10.4% and in the last two weeks 6.5%. Two point five percent of the patients had a new chemotherapy regimen in the last month of life (LMOL). Patients who didn’t undergo chemotherapy in the LMOL had a median overall survival (OS) of 10.36 months, while median OS for patients who received chemotherapy in the LMOL was 6.86 months (p=0.128). Median survival for patients who didn’t undergo chemotherapy in the last 14 days before death was 9.96 months while median survival for patients who underwent chemotherapy in the last 14 days was 6.83 months (p=0.763). Conclusion. Our results showed that no survival benefit was found in continuing chemotherapy in the LMOL. Further study is needed to better identify predictors of aggressive care near the EOL.

Authors and Affiliations

Saoussen BACHA

Keywords

Related Articles

Screening for tuberculosis using the MTB/RIF test in Guinea's prisons during 2018

Objective. To contribute to make better for tuberculosis infection in the prisons in Guinea. Methodology. This is a descriptive and analytical prospective study of active TB screening in the Central House and 7 regional...

Knowledge, attitudes, and practices of physical education and sports teachers on asthma in Lomé

Introduction. The prevalence of asthma is high in schools with a frequent occurrence of crises during sports activities. Physical education and sports (PES) teachers are often the first witnesses of these crises. The obj...

Respiratory manifestation showing a pyloric syndrome in young adult

Antropyloric stenosis is either ulcerative, tumoral or more rarely caustic. They are responsible for a syndrome of upper digestive obstruction, combining nausea and vomiting, dilation of the stomach with food and fluid s...

Management of spontaneous hemothorax and hemo-pneumo thorax

Spontaneous hemothorax corresponds to an accumulation of blood in the pleural cavity outside of any traumatic context. It is a rare clinical entity whose etiologies are generally reported in the form of clinical cases or...

Surgical management of bronchiectasis: What quality of life?

Introduction. The dilation of the bronchi is a serious disease, potentially disabling, causing a social repercussion. Methods. This retrospective study evaluates the indications and results of 41 patients operated for br...

Download PDF file
  • EP ID EP367848
  • DOI 10.12699/jfvpulm.8.25.2017.8
  • Views 79
  • Downloads 0

How To Cite

Saoussen BACHA (2017). Chemotherapy use at the end of life in metastatic non small cell lung cancer: practical analysis. JOURNAL OF FUNCTIONAL VENTILATION AND PULMONOLOGY, 8(25), 8-13. https://europub.co.uk/articles/-A-367848